COMPARISON BETWEEN INSULIN-INDUCED HYPOGLYCEMIA AND GROWTH-HORMONE (GH)-RELEASING HORMONE PLUS ARGININE AS PROVOCATIVE TESTS FOR THE DIAGNOSIS OF GH DEFICIENCY IN ADULTS
G. Aimaretti et al., COMPARISON BETWEEN INSULIN-INDUCED HYPOGLYCEMIA AND GROWTH-HORMONE (GH)-RELEASING HORMONE PLUS ARGININE AS PROVOCATIVE TESTS FOR THE DIAGNOSIS OF GH DEFICIENCY IN ADULTS, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1615-1618
There is now wide consensus that, within an appropriate clinical conte
xt, GH deficiency (GHD) in adults must be shown biochemically by provo
cative testing of GH secretion and that appropriate cut-off limits hav
e to be defined for each provocative test. Insulin-induced hypoglycemi
a (ITT) is indicated as the test of choice, and severe GHD, to be trea
ted with recombinant human GH replacement, is de fined by a GH peak re
sponse to ITT of less than 3 mu g/L. GKRH + arginine (GHRH+ARG) is one
of the most promising tests in alternative to ITT. In fact, it has be
en reported as a potent, reproducible, and age-independent test and th
at it is able to distinguish between GHD and normal adults. The aim of
the present study was to compare the GH response to ITT and GHRH+ARG
in a large group of hypopituitary adults (n = 40; 29 male and 11 femal
e; age: 36.4 +/- 2.1 yr). The third centile limit of the peak GH respo
nse to ITT has been reported as 5 mu g/L, whereas in our lab, that to
GHRH+ARG is 16.5 mu g/L. In hypopituitary adults, the mean peak GH res
ponse to ITT (1.5 +/- 0.2 mu g/L, range: 0.1-8.5 mu g/L)) was lower (P
< 0.001) than that to GHRH+ARG (3.0 +/- 0.4 mu g/L, range 0.1-12.0 mu
g/L), though there was positive correlation (r = 0.61, P < 0.001) bet
ween the GH responses to the 2 tests. The peak GH response to GHRH+ARG
, but not that to ITT, was positively (though weakly) associated with
insulin-like growth factor-I levels (r = 0.35, P < 0.03). Childhood an
d adult onset GKD patients, as well as patients with single and multip
le pituitary insufficiencies, had similar peak GH responses to ITT or
GHRH+ARG. Analyzing individual GH responses, 4/40 (10%) of the hypopit
uitary patients had GH peaks higher than 5 mu g/L after ITT; moreover,
3 other patients (7%) had GH peaks, after ITT, higher than 3 mu g/L.
On the other hand, after GHRH+ARG, all patients had GH peaks lower tha
n 16.5 mu g/L, whereas 21/40 (52.5%) had GK peaks higher than 3 mu g/L
. Because 3 mu g/L is the arbitrary cut-off for ITT, the third centile
limit of which is 5 mu g/L, we arbitrarily considered 9 mu g/L as the
cut-off point for GHRH+ARG. It is noteworthy that 37/40 (92.5%) patie
nts had a GH peak, after GHRH+ARG, below this limit. In conclusion, ou
r present results confirm that the ITT test is a reliable provocative
test for the diagnosis of adult GKD, whereas they show that the GHRH+A
RG test is, at least, as sensitive as the ITT test (provided that appr
opriate cut-off limits are considered). Note that even the arbitrary c
ut-off point below which severe GHD is demonstrated has to be appropri
ate to the potency of the test.